Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 36 studies | 34% ± 10% | |
macrophage | 29 studies | 36% ± 14% | |
conventional dendritic cell | 27 studies | 47% ± 18% | |
classical monocyte | 24 studies | 39% ± 14% | |
monocyte | 20 studies | 32% ± 14% | |
memory B cell | 19 studies | 39% ± 10% | |
dendritic cell | 18 studies | 40% ± 21% | |
naive B cell | 17 studies | 31% ± 8% | |
microglial cell | 16 studies | 47% ± 21% | |
non-classical monocyte | 14 studies | 26% ± 9% | |
myeloid cell | 11 studies | 35% ± 10% | |
alveolar macrophage | 6 studies | 24% ± 6% | |
mononuclear phagocyte | 5 studies | 37% ± 19% | |
leukocyte | 4 studies | 38% ± 15% | |
precursor B cell | 4 studies | 28% ± 7% | |
immature B cell | 4 studies | 37% ± 10% | |
intermediate monocyte | 4 studies | 38% ± 16% | |
germinal center B cell | 3 studies | 37% ± 9% | |
neutrophil | 3 studies | 20% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 508.19 | 571 / 578 | 86% | 19.93 | 990 / 1155 |
brain | 70% | 205.65 | 1862 / 2642 | 99% | 53.60 | 697 / 705 |
breast | 69% | 101.50 | 315 / 459 | 97% | 22.48 | 1083 / 1118 |
prostate | 77% | 110.16 | 189 / 245 | 71% | 8.04 | 356 / 502 |
adrenal gland | 89% | 191.67 | 229 / 258 | 58% | 7.51 | 134 / 230 |
kidney | 55% | 85.56 | 49 / 89 | 91% | 30.91 | 820 / 901 |
intestine | 72% | 237.98 | 699 / 966 | 54% | 7.93 | 282 / 527 |
bladder | 67% | 99.48 | 14 / 21 | 56% | 10.17 | 284 / 504 |
ovary | 34% | 34.48 | 62 / 180 | 85% | 16.50 | 367 / 430 |
thymus | 33% | 52.71 | 215 / 653 | 82% | 14.59 | 497 / 605 |
pancreas | 23% | 25.94 | 77 / 328 | 89% | 24.34 | 158 / 178 |
uterus | 42% | 41.79 | 71 / 170 | 66% | 9.34 | 303 / 459 |
stomach | 38% | 41.65 | 135 / 359 | 63% | 10.72 | 179 / 286 |
lymph node | 0% | 0 | 0 / 0 | 100% | 143.08 | 29 / 29 |
spleen | 100% | 2389.17 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 1760.02 | 928 / 929 | 0% | 0 | 0 / 0 |
skin | 19% | 16.67 | 348 / 1809 | 77% | 18.16 | 363 / 472 |
liver | 33% | 43.84 | 75 / 226 | 55% | 7.35 | 223 / 406 |
adipose | 83% | 186.14 | 999 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 15.12 | 37 / 45 |
esophagus | 27% | 30.32 | 397 / 1445 | 50% | 7.30 | 92 / 183 |
blood vessel | 72% | 159.45 | 960 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 46% | 5.77 | 37 / 80 |
heart | 33% | 37.06 | 281 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 1.13 | 11 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0031663 | Biological process | lipopolysaccharide-mediated signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_0045087 | Biological process | innate immune response |
GO_0031666 | Biological process | positive regulation of lipopolysaccharide-mediated signaling pathway |
GO_0005576 | Cellular component | extracellular region |
GO_0005515 | Molecular function | protein binding |
Gene name | LY86 |
Protein name | Lymphocyte antigen 86 (Ly-86) (Protein MD-1) |
Synonyms | MD1 |
Description | FUNCTION: May cooperate with CD180 and TLR4 to mediate the innate immune response to bacterial lipopolysaccharide (LPS) and cytokine production. Important for efficient CD180 cell surface expression (By similarity). . |
Accessions | ENST00000230568.5 O95711 ENST00000379953.6 |